Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysis

Debate remains over the role of rituximab, a large molecule with reduced central nervous system (CNS) penetration, in therapy for primary CNS lymphoma (PCNSL). Since 2013, the National Cancer Database has distinguished between chemotherapy and immunotherapy for frontline treatment. In this setting,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ollila, Thomas A., Taher, Rashida, Moku, Prashanth, Olszewski, Adam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515309/
https://www.ncbi.nlm.nih.gov/pubmed/37459209
http://dx.doi.org/10.1182/bloodadvances.2023010352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515309/
https://www.ncbi.nlm.nih.gov/pubmed/37459209
http://dx.doi.org/10.1182/bloodadvances.2023010352

Ejemplares similares